Paul Tudor Jones Codexis, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Codexis, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 58,093 shares of CDXS stock, worth $297,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,093
Previous 99,686
41.72%
Holding current value
$297,436
Previous $309,000
42.39%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CDXS
# of Institutions
125Shares Held
59.9MCall Options Held
25.9KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.77MShares$44.9 Million4.93% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$41.5 Million1.94% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.15MShares$21.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.97MShares$15.2 Million0.54% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $335M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...